{
  "id": 14621032,
  "title": "Laurus Labs Invests ₹107.8 Crore In KRKA Pharma, Maintains 49% Stake",
  "url": "https://urgent.news/2026/10/15/laurus-labs-invests-107-8-crore-in-krka-pharma-maintains-49-stake",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-15T05:13:54.000Z",
  "source": {
    "name": "Free Press Journal",
    "slug": "free-press-journal",
    "url": "https://www.freepressjournal.in/business/laurus-labs-invests-1078-crore-in-krka-pharma-maintains-49-stake"
  },
  "original_language": "en",
  "account": "Mumbai: Laurus Labs Limited has recently committed ₹107.8 crore to KRKA Pharma Private Limited through a rights issue, according to an October 14, 2026 announcement. The pharmaceutical company acquired 10.78 crore equity shares, each with a face value of ₹10. This investment occurs following a previous disclosure made on April 30, 2026, linking it to the company's investment plans. The transaction results in Laurus Labs maintaining its 49% stake in the joint venture. Following the investment, Laurus Labs' total holding in KRKA Pharma stands at 26.215 crore equity shares.",
  "summary": "Mumbai: Laurus Labs Limited has invested ₹107.8 crore in KRKA Pharma Private Limited through a rights issue, according to a company announcement dated October 14, 2026. The pharmaceutical company acquired 10.78 crore equity shares with a face value of ₹10 each. The investment follows an earlier intimation submitted on April 30, 2026, linking the latest disclosure to its previously communicated…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}